| |
|
Dear Healthcare Professional,
Welcome to the June edition of our email newsletters aimed to keep you updated with the latest in infant nutrition to help you support parents. This month we are discussing the management of reflux in babies and encouraging you to get in touch with suggestions of what you want to see on our website to best support you in your role.
Kind regards,
The SMA® Professional Team |
|
 |
|
|
|
| Managing reflux in babies |
|
 |
|
Gastroesophageal reflux (GOR) is the passage of gastric contents into the oesophagus which occurs widely in healthy newborns. It is considered normal and as long as there are no other symptoms and the baby is growing well, you can reassure parents that reflux is not a major concern1. However, there are tips you can share with parents to help them manage their baby’s reflux- viewable here.
Did you know that NICE 2015 guidelines recommend the use of an anti-reflux formula before alginate therapy in infants with frequent regurgitation associated with marked distress?2 Read our summary of these NICE guidelines to support you to help parents with babies experiencing reflux. |
|
 |
|
|
|
|
|
|
|
 |
|
| Further information on these adaptations is available on our website. |
|
| The packaging was updated in May to include ‘Anti- reflux’ to help parents better understand its intended use. View our comparison chart to see how SMA Staydown ® Anti-reflux compares to other anti-reflux formulas. |
|
 |
|
|
|
|
|
|
The SMA Professional website has been created to support you in your healthcare professional role. In our resources section you will find summaries of clinical papers and thought provoking articles to broaden and develop your expertise in infant nutrition. You will also find a range of unbranded helpsheets in 7 languages covering topics from steam sterilising to breastfeeding positions to support you in your conversations with parents.
We want to ensure you find the resources you need to support you in your role and welcome all suggestions about what you would like to find on the website. Email us here with suggestions of content you would find useful. |
|
 |
|
|
|
|
|
|
® Registered Trademark.
IMPORTANT NOTICE: The World Health Organisation (WHO) has recommended that pregnant women and new mothers be informed on the benefits and superiority of breastfeeding – in particular the fact that it provides the best nutrition and protection from illness for babies. Mothers should be given guidance on the preparation for, and maintenance of, lactation, with special emphasis on the importance of a well-balanced diet both during pregnancy and after delivery. Unnecessary introduction of partial bottle-feeding or other foods and drinks should be discouraged since it will have a negative effect on breastfeeding. Similarly, mothers should be warned of the difficulty of reversing a decision not to breastfeed. Before advising a mother to use an infant formula, she should be advised of the social and financial implications of her decision: for example, if a baby is exclusively bottle-fed, more than one can (400 g) per week will be needed, so the family circumstances and costs should be kept in mind. Mothers should be reminded that breast milk is not only the best, but also the most economical food for babies. If a decision to use an infant formula is taken, it is important to give instructions on correct preparation methods, emphasising that unboiled water, unsterilised bottles or incorrect dilution can all lead to illness. This product must be used under medical supervision. SMA Staydown is a special formula intended for the dietary management of bottle-fed babies when significant reflux (regurgitation) is a problem. It is suitable as the sole source of nutrition up to 6 months of age, and in conjunction with solid food up to 12 months of age. If the baby’s reflux does not improve within 2 weeks of starting SMA Staydown, or if the baby fails to thrive, the family doctor should be consulted.
References: 1. Hyman PE et al. Gastroenterology 2006; 130: 1519–1526 2. National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summary: GORD in children. March 2015. Available here. |
|
|
|
|
|
|
|
